Description
Cerebrolysin is a mixture of short peptides and amino acids produced by enzymatically breaking down porcine (pig) brain proteins. It is marketed in many countries for neurological recovery after stroke, traumatic brain injury (TBI), and some forms of cognitive impairment/dementia, but it is not FDA‑approved in the U.S. Product is typically administered by infusion or injection, not orally.






There are no reviews yet.